In Vivo CYP3A4 Activity, CYP3A5 Genotype, and Hematocrit Predict Tacrolimus Dose Requirements and Clearance in Renal Transplant Patients
収録刊行物
-
- Clinical Pharmacology & Therapeutics
-
Clinical Pharmacology & Therapeutics 92 (3), 366-375, 2012-08-08
Wiley